Multicentre European phase IIb study of ICES 13 for the treatment of stress urinary incontinence

Trial Profile

Multicentre European phase IIb study of ICES 13 for the treatment of stress urinary incontinence

Completed
Phase of Trial: Phase II

Latest Information Update: 29 Jun 2016

At a glance

  • Drugs ICES 13 (Primary)
  • Indications Stress incontinence
  • Focus Therapeutic Use
  • Sponsors Innovacell Biotechnologie GmbH
  • Most Recent Events

    • 04 Mar 2015 New source identified and integrated (European Clinical Trials database:2014-001656-34)
    • 04 Mar 2015 According to the European Clinical Trials database record, planned number of patients changed to 88.
    • 31 Dec 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top